Sanjay Awasthi
Affiliations: | 2016- | Internal Medicine, Division of Heme/Onc | Texas Tech University Health Sciences Center, Lubbock, TX |
Area:
Biochemistry; Glutathione; Ralbp1; TP53; Antioxidants; CacinogenesisGoogle:
"Sanjay Awasthi"Mean distance: (not calculated yet)
Parents
Sign in to add mentorYogesh C. Awasthi | research assistant | 1978-1985 | UTMB, Galveston | |
Satish K. Srivastava | research assistant | 1978-1985 | UTMB | |
John D. Minna | post-doc | 1990-1991 | University of Texas Southwestern Medical Center at Dallas | |
Eugene P. Frenkel | research scientist | University of Texas Southwestern Medical Center at Dallas | ||
Patricia A. Gwirtz | research scientist | 2009 | UT Arlington (Physiology Academic Tree) | |
(M.S.) |
Children
Sign in to add traineeEwa Zajac | grad student | 2006 | UT Arlington |
Kenneth Drake | grad student | 2007 | UT Arlington |
Dilki C. Wickramarachchi | grad student | 2007 | UT Arlington |
Lokesh P. Dalasanur Nagaprashantha | grad student | 2011 | University of North Texas Health Science Center at Fort Worth (Cell Biology Tree) |
Archana Seharawat | grad student | 2007-2013 | University of North Texas Health Science Center at Fort Worth |
Sharad S. Singhal | post-doc | 1994-2016 | UT Arlington |
Collaborators
Sign in to add collaboratorSharad S. Singhal | collaborator | 2011- | City of Hope and Beckman Research Institute |
Yogesh C. Awasthi | collaborator | 1991-1999 | UTMB |
Satish K. Srivastava | collaborator | 1991-2019 | UTMB, Galveston |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ramisetty SK, Garg P, Mohanty A, et al. (2023) Regression of ovarian cancer xenografts by depleting or inhibiting RLIP. Biochemical Pharmacology. 217: 115847 |
Garg P, Awasthi S, Horne D, et al. (2023) The innate effects of plant secondary metabolites in preclusion of gynecologic cancers: Inflammatory response and therapeutic action. Biochimica Et Biophysica Acta. Reviews On Cancer. 188929 |
Garg P, Garg R, Horne D, et al. (2023) Prognostic significance of natural products against multidrug tumor resistance. Cancer Letters. 557: 216079 |
Singhal SS, Garg R, Horne D, et al. (2022) RLIP: A necessary transporter protein for translating oxidative stress into pro-obesity and pro-carcinogenic signaling. Biochimica Et Biophysica Acta. Reviews On Cancer. 188803 |
Nagaprashantha LD, Singhal J, Li H, et al. (2022) Correction: 2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer. Oncotarget. 13: 331 |
Bose C, Hindle A, Lee J, et al. (2021) Anticancer Activity of Ω-6 Fatty Acids through Increased 4-HNE in Breast Cancer Cells. Cancers. 13 |
Singh SP, Lee J, Bose C, et al. (2021) Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary Carcinogenesis. Cancers. 13 |
Singhal SS, Srivastava S, Mirzapoiazova T, et al. (2021) Targeting the mercapturic acid pathway for the treatment of melanoma. Cancer Letters |
Singhal SS, Mohanty A, Kulkarni P, et al. (2021) RLIP Depletion Induces Apoptosis Associated with Inhibition of JAK2/STAT3 Signaling in Melanoma Cells. Carcinogenesis |
Singhal J, Kulkarni P, Horne D, et al. (2021) Prevention of mammary carcinogenesis in MMTV-neu mice by targeting RLIP. Molecular Carcinogenesis |